President & Chief Executive Officer, Board Member

Chief Financial Officer

Clear Street Initiates Buy on Dianthus Therapeutics, Inc. (DNTH) With $100 Price Target

Dianthus initiated with bullish view at Clear Street, here's why

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering

Senior Director, Publications and Medical Communications

Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative monoclonal antibodies for severe autoimmune and inflammatory diseases. The Senior Director, Publications and Medical Communications will lead the development and dissemination of scientific and medical information to support the company's products and pipeline, ensuring alignment with corporate objectives and compliance standards.

Sign up with Google

Sign in with Google